Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe M Weinstein

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of Addiction Medicine|December 16, 2020
A Pilot Study of Automated Pupillometry in the Treatment of Opioid Use DisorderCrandall E Peeler, Merit Gorgy, Natalie Sadlak, et al.
Drug and Alcohol Dependence|April 25, 2026
Implementation of addiction consult services and bridge clinics in the HEALing communities study in MassachusettsZoe M Weinstein, Elizabeth Jadovich, Mari-Lynn Drainoni, et al.
Substance Use & Misuse|January 25, 2023
Pre-Paid Phone Distribution: A Tool for Improving Healthcare Engagement for People with Substance Use DisorderAlyssa F Peterkin, Raagini Jawa, Kalil Menezes, et al.
Journal of Substance Abuse Treatment|January 31, 2017
Long-term retention in Office Based Opioid Treatment with buprenorphineZoe M Weinstein, Hyunjoong W Kim, Debbie M Cheng, et al.
Addiction Science & Clinical Practice|March 3, 2025
Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative studyMelissa Davoust, Angela R Bazzi, Samantha Blakemore, et al.
Substance Use & Addiction Journal|August 28, 2025
Patient and Provider Perspectives on the Elimination of Urine Drug Testing in Office-Based Addiction TreatmentJacqueline Theisen, Zoe M Weinstein, Melissa Davoust, et al.
Research Square|May 15, 2024
Patient and Clinician Experiences with the Implementation of Telemedicine and Related Adaptations in Office-Based Buprenorphine Treatment During the COVID-19 Pandemic: A Qualitative StudyMelissa Davoust, Angela R Bazzi, Samantha Blakemore, et al.
Drug and Alcohol Dependence|May 24, 2022
Bridge clinic implementation of "72-hour rule" methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in careJessica L Taylor, Jordana Laks, Paul J Christine, et al.
Journal of Substance Use|June 22, 2026
Impacts of personal or family COVID-19 infection on health-related quality of life among patients with opioid use disorderZoe M Weinstein, Kara M Magane, Sara Lodi, et al.
Addiction Science & Clinical Practice|December 2, 2024
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorderGavin Bart, Kelly S Barth, Paulette Baukol, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Addiction Medicine|December 16, 2020
A Pilot Study of Automated Pupillometry in the Treatment of Opioid Use DisorderCrandall E Peeler, Merit Gorgy, Natalie Sadlak, et al.
Drug and Alcohol Dependence|April 25, 2026
Implementation of addiction consult services and bridge clinics in the HEALing communities study in MassachusettsZoe M Weinstein, Elizabeth Jadovich, Mari-Lynn Drainoni, et al.
Substance Use & Misuse|January 25, 2023
Pre-Paid Phone Distribution: A Tool for Improving Healthcare Engagement for People with Substance Use DisorderAlyssa F Peterkin, Raagini Jawa, Kalil Menezes, et al.
Journal of Substance Abuse Treatment|January 31, 2017
Long-term retention in Office Based Opioid Treatment with buprenorphineZoe M Weinstein, Hyunjoong W Kim, Debbie M Cheng, et al.
Addiction Science & Clinical Practice|March 3, 2025
Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative studyMelissa Davoust, Angela R Bazzi, Samantha Blakemore, et al.
Substance Use & Addiction Journal|August 28, 2025
Patient and Provider Perspectives on the Elimination of Urine Drug Testing in Office-Based Addiction TreatmentJacqueline Theisen, Zoe M Weinstein, Melissa Davoust, et al.
Research Square|May 15, 2024
Patient and Clinician Experiences with the Implementation of Telemedicine and Related Adaptations in Office-Based Buprenorphine Treatment During the COVID-19 Pandemic: A Qualitative StudyMelissa Davoust, Angela R Bazzi, Samantha Blakemore, et al.
Drug and Alcohol Dependence|May 24, 2022
Bridge clinic implementation of "72-hour rule" methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in careJessica L Taylor, Jordana Laks, Paul J Christine, et al.
Journal of Substance Use|June 22, 2026
Impacts of personal or family COVID-19 infection on health-related quality of life among patients with opioid use disorderZoe M Weinstein, Kara M Magane, Sara Lodi, et al.
Addiction Science & Clinical Practice|December 2, 2024
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorderGavin Bart, Kelly S Barth, Paulette Baukol, et al.
Pageof 6